Post Market TRUST - U.S.A. Study

  • Interventional
  • Active
  • NCT02163525

The TRUST (Treatment Results of Uterine Sparing Technologies) U.S.A. Study

This Post Market study is being conducted to compare the direct and indirect cost of three approaches (GFA, myomectomy, and uterine artery embolization) for the treatment of symptomatic uterine fibroids. In addition, data from this study is being used to satisfy the requirements of the United States Food and Drug Administration's 522 (post market surveillance) order.